Advances in counselling and surveillance of patients at risk for pancreatic cancer: Table 1
Randall Brand(NorthShore University HealthSystem), Marcia Irene Canto(Johns Hopkins University), Teresa A. Brentnall(University of Washington), Ralph H. Hruban(Johns Hopkins University), H. T. Lynch(Creighton University), Wendy S. Rubinstein(National Cancer Institute), Markus M. Lerch(Ludwig-Maximilians-Universität München), John P. Neoptolemos(University of Liverpool), David C. Whitcomb(Christian Medical College & Hospital)
Cited by 322
Related Papers
PD-1 Blockade in Tumors with Mismatch-Repair Deficiency
|New England Journal of Medicine|2015|9.4k
Core Signaling Pathways in Human Pancreatic Cancers Revealed by Global Genomic Analyses
|Science|2008|4k
Detection and localization of surgically resectable cancers with a multi-analyte blood test
|Science|2018|2.8k
Organoid Models of Human and Mouse Ductal Pancreatic Cancer
|Cell|2014|2.2k